Benzyl Bromide → 9-Benzyl-2-chloro-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one
Reaction equation
[Cl:1][C:2]1[N:3]=[CH:4][C:5]2[N:11]([CH3:12])[C:10](=[O:13])[C:9]([CH3:15])([CH3:14])[CH2:8][NH:7][C:6]=2[N:16]=1.[CH2:17](Br)[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1.[H-].[Na+]>CC(N(C)C)=O>[CH2:17]([N:7]1[CH2:8][C:9]([CH3:14])([CH3:15])[C:10](=[O:13])[N:11]([CH3:12])[C:5]2[CH:4]=[N:3][C:2]([Cl:1])=[N:16][C:6]1=2)[C:18]1[CH:23]=[CH:22][CH:21]=[CH:20][CH:19]=1Participants
5
Procedure
2-Chloro-8,9-dihydro-5,7,7-trimethyl-5H-pyrimido[4,5-b][1,4]diazepin-6(7H)-one (50 mg, 0.21 mmol) and benzylbromide (30 μl, 0.25 mmol) in DMA (0.5 ml) was treated with sodium hydride 60% oil dispersion (9 mg, 0.23 mmol) at room temperature. The mixture was stirred at room temperature for 5 hours. The reaction mixture was concentrated under reduced pressure. The residue was purified by column chromatography (50% EtOAc in hexanes, loaded on silica, ˜50 mL silica) to give the title compound as a white solid (63 mg, 91%). NMR DMSO D61.00 (6H, s), 3.22 (3H, s), 3.53 (2H, s), 4.91 (2H, s), 7.28-7.39 (5H, m), 8.12 (1H, s); MS (ES+) 331.
Workup
- concentrationThe reaction mixture was concentrated under reduced pressure
- customThe residue was purified by column chromatography (50% EtOAc in hexanes, loaded on silica, ˜50 mL silica)
Sources & evidence
- ORD record
- ord-4715ab8d81b9402fa80b1ac6f4616434
- Source dataset
- uspto-grants-2011_09
- Patent number
- US08022202B2
Reaction notes
Loading…